Reporter: Abigail Berman Milby, MD The Abramson Cancer Center of
the University of Pennsylvania Last Modified: May 21, 2012
William Chu, Berkeley National Laboratory (Moderator) Stephanie
Combs, University Hospital of Heidelberg Thomas DeLaney,
Massachusetts General Hospital Daniel Gomez, MD Anderson Cancer
Center Eugen Hug, ProCure Proton Therapy Center Roberto
Orecchia, ULICE Koji Tsuboi, PMRC Hirohiko Tsujii, NIRS Kwan Ho
Cho, NCC, Korea A panel discussion ensued regarding the
advantages and disadvantages of proton and carbon ion therapy.
The most salient points are summarized below, followed by a
description of specific questions that were raised and the
discussion that followed each. Proton therapy and carbon ion
therapy are both forms of particle therapy that can be used to
effectively treat tumors. Studies performed thus far have shown
approximate equivalence of both modalities, although the studies
are limited by comparison across multiple institutions and
different patient populations. The following